Stéphane De Wit

570 total citations
18 papers, 319 citations indexed

About

Stéphane De Wit is a scholar working on Infectious Diseases, Virology and Surgery. According to data from OpenAlex, Stéphane De Wit has authored 18 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Virology and 5 papers in Surgery. Recurrent topics in Stéphane De Wit's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Stéphane De Wit is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Stéphane De Wit collaborates with scholars based in Belgium, France and United States. Stéphane De Wit's co-authors include Nathan Clumeck, Marc Delforge, Carine Van Lint, Véronique Avettand-Fènoël, Christine Rouzioux, Anna Kula, Nadège Delacourt, Olivier Rohr, Gilles Darcis and Benoît Van Driessche and has published in prestigious journals such as PLoS ONE, PLoS Medicine and Frontiers in Immunology.

In The Last Decade

Stéphane De Wit

18 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane De Wit Belgium 10 196 185 92 64 45 18 319
Dragana Orlovic South Africa 7 142 0.7× 209 1.1× 150 1.6× 45 0.7× 55 1.2× 9 346
Marloes A. Naarding Netherlands 7 144 0.7× 90 0.5× 97 1.1× 78 1.2× 105 2.3× 7 332
Rahul Sampath United States 8 104 0.5× 106 0.6× 162 1.8× 22 0.3× 62 1.4× 20 306
Piera Pierotti Italy 10 272 1.4× 226 1.2× 74 0.8× 36 0.6× 104 2.3× 21 402
Christina Grube Switzerland 11 301 1.5× 278 1.5× 110 1.2× 43 0.7× 50 1.1× 17 405
Heather A. Pilch-Cooper United States 7 237 1.2× 122 0.7× 83 0.9× 31 0.5× 159 3.5× 8 351
A. Eiras Spain 9 177 0.9× 201 1.1× 138 1.5× 46 0.7× 18 0.4× 21 369
Madhuri Thakar India 10 156 0.8× 153 0.8× 87 0.9× 23 0.4× 46 1.0× 18 264
Carmela Ganoza Peru 9 160 0.8× 102 0.6× 86 0.9× 57 0.9× 135 3.0× 14 303
Daniel Muema United States 12 197 1.0× 189 1.0× 105 1.1× 44 0.7× 143 3.2× 21 371

Countries citing papers authored by Stéphane De Wit

Since Specialization
Citations

This map shows the geographic impact of Stéphane De Wit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Wit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Wit more than expected).

Fields of papers citing papers by Stéphane De Wit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane De Wit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Wit. The network helps show where Stéphane De Wit may publish in the future.

Co-authorship network of co-authors of Stéphane De Wit

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Wit. A scholar is included among the top collaborators of Stéphane De Wit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Wit. Stéphane De Wit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Scheerder, Marie‐Angélique De, Virginie Mortier, Chris Verhofstede, et al.. (2024). Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir. Frontiers in Immunology. 14. 1337316–1337316. 9 indexed citations
2.
Willems, Fabienne, Charlotte Martin, Déborah Konopnicki, et al.. (2024). HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy. EBioMedicine. 104. 105179–105179. 2 indexed citations
5.
Vanderpas, Jean, et al.. (2021). Failure to eradicate Helicobacter pylori infection is more frequent among HIV‐positive patients. HIV Medicine. 22(7). 547–556. 7 indexed citations
6.
Libois, Agnès, Marie Hallin, Tania Crucitti, Marc Delforge, & Stéphane De Wit. (2018). Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study. PLoS ONE. 13(4). e0196217–e0196217. 15 indexed citations
7.
Gharu, Lavina, Anna Kula, Alexander Pasternak, et al.. (2018). Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. mBio. 9(6). 30 indexed citations
9.
Libois, Agnès, Francesco Feoli, Marc Delforge, et al.. (2016). Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study. Sexually Transmitted Infections. 93(1). 15–17. 18 indexed citations
10.
Darcis, Gilles, Sophie Bouchat, Anna Kula, et al.. (2016). Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir. AIDS. 31(2). 181–189. 29 indexed citations
11.
Darcis, Gilles, Sophie Bouchat, Anna Kula, et al.. (2016). Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir. Journal of Virus Eradication. 2. 10–10. 2 indexed citations
12.
Wit, Stéphane De, Vinciane Muls, Marc Delforge, et al.. (2015). HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors. PLoS ONE. 10(12). e0145119–e0145119. 7 indexed citations
13.
Bouchat, Sophie, Nadège Delacourt, Anna Kula, et al.. (2015). Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV ‐1. EMBO Molecular Medicine. 8(2). 117–138. 70 indexed citations
14.
Laethem, Kristel Van, Yoeri Schrooten, Philippe Lemey, et al.. (2004). A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. Journal of Virological Methods. 123(1). 25–34. 42 indexed citations
15.
Wit, Stéphane De, Ronan Boulmé, Bénédicte Poll, Jean‐Claude Schmit, & Nathan Clumeck. (2004). Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients. AIDS. 18(17). 2330–2331. 26 indexed citations
16.
Denning, David W., et al.. (1994). Treatment of Fluconazole resistant oral candidosis with D0870 in patients with AIDS. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2 indexed citations
17.
Wit, Stéphane De, et al.. (1991). Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. European Journal of Clinical Microbiology & Infectious Diseases. 10(6). 503–505. 20 indexed citations
18.
Wit, Stéphane De & Nathan Clumeck. (1989). Fluconazole in the treatment of fungal infections associated with AIDS. Infection. 17(3). 121–123. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026